Rilutek Prolongs Survival of ALS Patients in Later Stages, Study Shows
Rilutek (riluzole) extends survival of patients with amyotrophic lateral sclerosis (ALS) who are at advanced stages of the…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Rilutek (riluzole) extends survival of patients with amyotrophic lateral sclerosis (ALS) who are at advanced stages of the…
Newly identified mutations in the KIF5A gene were recently found to contribute to amyotrophic lateral sclerosis (ALS), the result…
After eight years of research, scientists have finally discovered how TDP-43 and hnRNP A1 — two proteins that have…
Nerve cells that control movement change their size as ALS progresses, becoming larger than normal at first but then ending…
Some immune cells in the brain can protect it from the damaging effects of faulty TDP-43 protein, preventing the progression…
ALS patients who took Rilutek (riluzole) for at least three-fourths of the time they had their disease survived longer…
Fat molecules appear to play a role in the development of ALS, which means that targeting them could be a…
The amount of RNA molecules present in the blood and central nervous system of amyotrophic lateral sclerosis (ALS) patients seems to…
University of North Carolina researchers have identified the DNA sequence in a virus that lets it deliver treatments for neurodegenerative diseases…
UCLA researchers have identified the regulatory network that controls the transformation of neuronal progenitor cells into movement nerve cells in…